Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops REC 0545 for acute decompensation in m… Read more
Market Cap & Net Worth: Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY)
Recordati Industria Chimica e Farmaceutica S.p.A. (PINK:RICFY) has a market capitalization of $11.76 Billion ($11.76 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #5684 globally and #3312 in its home market, demonstrating a -0.59% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Recordati Industria Chimica e Farmaceutica S.p.A.'s stock price $14.41 by its total outstanding shares 816010164 (816.01 Million).
Recordati Industria Chimica e Farmaceutica S.p.A. Market Cap History: 2023 to 2025
Recordati Industria Chimica e Farmaceutica S.p.A.'s market capitalization history from 2023 to 2025. Data shows growth from $10.86 Billion to $11.76 Billion (0.00% CAGR).
Recordati Industria Chimica e Farmaceutica S.p.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Recordati Industria Chimica e Farmaceutica S.p.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.58x
Recordati Industria Chimica e Farmaceutica S.p.A.'s market cap is 4.58 times its annual revenue
0.84x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
25.76x
Recordati Industria Chimica e Farmaceutica S.p.A.'s market cap is 25.76 times its annual earnings
11.15x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $10.86 Billion | $2.08 Billion | $389.21 Million | 5.22x | 27.91x |
| 2024 | $10.73 Billion | $2.34 Billion | $416.51 Million | 4.58x | 25.76x |
Competitor Companies of RICFY by Market Capitalization
Companies near Recordati Industria Chimica e Farmaceutica S.p.A. in the global market cap rankings as of March 18, 2026.
Key companies related to Recordati Industria Chimica e Farmaceutica S.p.A. by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
Recordati Industria Chimica e Farmaceutica S.p.A. Historical Marketcap From 2023 to 2025
Between 2023 and today, Recordati Industria Chimica e Farmaceutica S.p.A.'s market cap moved from $10.86 Billion to $ 11.76 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $11.76 Billion | +9.58% |
| 2024 | $10.73 Billion | -1.23% |
| 2023 | $10.86 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Recordati Industria Chimica e Farmaceutica S.p.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.76 Billion USD |
| MoneyControl | $11.76 Billion USD |
| MarketWatch | $11.76 Billion USD |
| marketcap.company | $11.76 Billion USD |
| Reuters | $11.76 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.